David Lee received his B.S. in biology from Stanford University and his PhD in biochemistry from the University of Washington. With the support of the Helen Hay Whitney Foundation, he completed postdoctoral fellowships at Washington University (biochemistry) and the University of Washington (pharmacology). From 1983 to 1985, he worked as a senior scientist at Oncogen, which was acquired by Bristol Myers Squibb during this period. In 1985, Lee joined the University of North Carolina at Chapel Hill as a member of the Lineberger Comprehensive Cancer Center and a faculty member in the Department of Microbiology and Immunology. In 1991 he was appointed Scientific Program Leader for Cell Biology in the Lineberger Comprehensive Cancer Center, and in 1998 he was appointed the head of the Department of Biochemistry and Biophysics. In 2005, Lee moved to the University of Georgia to become the vice president for research and executive vice president of the UGA Research Foundation, with an appointment as professor of biochemistry and molecular biology. He serves on the boards of several national organizations, including the Southeastern University Research Association and the U.S. Department of Energy’s Center for BioEnergy Innovation, headquartered at Oak Ridge National Lab (Tennessee), and he recently completed service as president of the board of the Oak Ridge Associated Universities. He was elected a Fellow of the American Association for the Advancement of Science in 2004. At UNC, his research focused on the molecular regulation of cellular growth and differentiation by epidermal growth factor-like proteins and especially transforming growth factor-alpha.